By Mellanie True Hills Summary: StopAfib.org unveils the Top Ten Atrial Fibrillation Articles of 2011, indicating that patients are focused on afib stroke prevention and atrial fibrillation procedures. Approximate reading time: 2–4 minutes December 29, 2011 — Yesterday, StopAfib.org announced the first of our 2011 Top Ten Lists, the Top Ten Atrial Fibrillation Videos of …
Read More
By Mellanie True Hills Summary: StopAfib.org unveils the Top Ten Atrial Fibrillation Videos of 2011, indicating the priorities of the afib community this year. Approximate reading time: 2 minutes December 28, 2011 — Today, StopAfib.org announces the first of our Top Ten Lists, the Top Ten Atrial Fibrillation Videos of 2011. 2011 Most Viewed Afib …
Read More
By Christine Welniak Summary: An FDA advisory panel concluded that the benefits outweighed the risks when using the Synergy bipolar radiofrequency clamp during open heart surgeries for treating persistent and longstanding persistent atrial fibrillation. FDA approval was granted December 16, 2012. Reading time: Approximately 4-6 minutes December 16, 2011 — Update: The Food and Drug …
Read More
By Mellanie True Hills December 12, 2011 Summary: One of the newest frontiers in atrial fibrillation catheter ablation is focal and rotor ablation. In this video, Dr. Sanjiv Narayan talks about the results of the FIRM trial that he presented at the American Heart Association Scientific Sessions 2011. Reading and watching time is approximately 6 …
Read More
By Jennifer L.W. Fink Summary: The drug apixaban (Eliquis) was shown to be superior to warfarin for atrial fibrillation stroke prevention in a large study that was published in the New England Journal of Medicine. FDA approval of the drug is expected by March 28, 2012. Approximate reading time: 3–5 minutes November 30, 2011 — …
Read More
By Mellanie True Hills November 28, 2011 Summary: Atrial fibrillation ablation results vary between women and men according to the poster presented by Dr. John Mandrola at the American Heart Association Scientific Sessions 2011. Reading and watching time is approximately 4 minutes In this video interview at the American Heart Association Scientific Sessions 2011, Dr. …
Read More
November 10, 2011 Summary: Here is the transcript of our October 28 afib community chat with the atrial fibrillation experts at the Cleveland Clinic, which provided a rare opportunity to get answers to the most pressing questions of the afib community. There were too many questions to answer during the chat, but the doctors generously …
Read More
By Mellanie True Hills Summary: The FDA has approved a second alternative to warfarin, Xarelto (rivaroxaban), for stroke prevention in atrial fibrillation. Approximate reading time: 2–4 minutes November 4, 2011 — The U.S. Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those who have non-valvular atrial fibrillation (afib that is …
Read More
By Mellanie True Hills October 24, 2011 Summary: This video discusses the CHA2DS2-VASc tool for predicting stroke risk in atrial fibrillation and why aspirin should not be used for stroke prevention. Reading and watching time is approximately 10 minutes In this video interview, Dr. Gregory Lip, Professor of Cardiovascular Medicine at the University of Birmingham …
Read More
October 17, 2011 Summary: Take advantage of this unique opportunity to chat live on October 28, 2011, with atrial fibrillation experts from the Cleveland Clinic and the founder of StopAfib.org. Our previous chat with doctors from the Cleveland Clinic was so popular that they have agreed to do another one. Please join us on October …
Read More